Erythema Pernio-Like in Four Adolescents in the Era of the Coronavirus-2 Infection

Author(s): Luigi Promenzio, Fabio Arcangeli, Elisabetta Cortis, Elisa Sama, Federico Longhini*

Journal Name: Reviews on Recent Clinical Trials

Volume 16 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Although epidemic, novel coronavirus (SARS-CoV-2) infection rarely affects the pediatric population. However, in the last months, an increasing number of Italian pediatricians have reported the occurrence of erythema pernio-like in children following a flu-like syndrome, after the outbreak of SARS-CoV-2 infection.

Objective: The study aims to report cutaneous manifestation of SARS-CoV-2 infection in 4 adolescents.

Methods: Observational study reporting 4 adolescents with skin lesions, 2 weeks after the occurrence of a flu-like syndrome.

Results: Fourteen days after a flu-like syndrome, adolescents exhibited skin lesions to toes and feet. These lesions were rounded, with blurred limits, with a 5-15 mm diameter, red-violaceous- bluish colored, sometimes resulting in bullous lesions in correspondence of the central or apical portion, which tended to be covered with blackish crusts after evolution. Lesions were also accompanied by pain of variable intensity and evolved within two or three weeks to self-resolution without particular sequelae. In two patients, pharyngeal and nasal swabs were negative for SARSCoV- 2 infection, at the presentation of skin lesions. After 2 months from clinical manifestations, patients were tested positive for SARS-CoV-2 antibodies.

Conclusions: In the pediatric and adolescent population, the occurrence of an erythema pernio-like after a flu-like syndrome could be associated with SARS-CoV-2 infection.

Keywords: Erythema pernio-like, coronavirus, COVID-19, SARS-CoV-2, Chilblain-like lesion, children, pediatric population.

[1]
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33.[http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]
[2]
Froes F. And now for something completely different: From 2019-nCoV and COVID-19 to 2020-nMan. Pulmonology 2020; 26(2): 114-5.[http://dx.doi.org/10.1016/j.pulmoe.2020.02.010] [PMID: 32151613]
[3]
Gentile I, Abenavoli L. COVID-19: Perspectives on the Potential Novel Global Threat. Rev Recent Clin Trials 2020; 15(2): 84-6.[http://dx.doi.org/10.2174/1574887115999200228100745] [PMID: 32116200]
[4]
Mendez-Sanchez N, Valencia-Rodriguez A, Qi X, Yoshida EM, Romero-Gomez M, George J, et al. What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective. J Clin Transl Hepatol 2020; 8(2): 0024.
[5]
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323(13): 1239-42.[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[6]
Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020; 382(17): 1663-5.[http://dx.doi.org/10.1056/NEJMc2005073] [PMID: 32187458]
[7]
Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA 2020; 323(16): 1545-6.[http://dx.doi.org/10.1001/jama.2020.4031] [PMID: 32167538]
[8]
Abenavoli L, Cinaglia P, Luzza F, Gentile I, Boccuto L. Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. Rev Recent Clin Trials 2020.
[9]
Zhang Y, Cao W, Xiao M, et al. [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia]. Zhonghua Xue Ye Xue Za Zhi 2020; 41(0): E006.[PMID: 32220276]
[10]
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, et al. Comment on “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”. J Am Acad Dermatol 2020; 83(3): e241.[http://dx.doi.org/10.1016/j.jaad.2020.05.120] [PMID: 32497704]
[11]
Kolivras A, Dehavay F, Delplace D, Feoli F, Meiers I, Milone L, et al. Coronavirus (COVID-19) infection-induced chilblains: A case report wth histopathological findings. JAAD Case Rep 2020.[http://dx.doi.org/10.1016/j.jdcr.2020.04.011]
[12]
Colmenero I, Santonja C, Alonso-Riano M, Noguera-Morel L, Hernandez-Martin A, Andina D, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: Histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases. Br J Dermatol 2020; 183(4): 729-37.[http://dx.doi.org/10.1111/bjd.19327]
[13]
Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, et al. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach. J Eur Acad Dermatol Venereol 2020; 34(11): e659-62.[http://dx.doi.org/10.1111/jdv.16745] [PMID: 32535943]
[14]
Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol 2020; 34(5): e212-3.[http://dx.doi.org/10.1111/jdv.16387] [PMID: 32215952]
[15]
Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, et al. Major cluster of pediatric ” true ” primary chilblains during the COVID-19 pandemic: A consequence of lifestyle changes due to lockdown. J Eur Acad Dermatol Venereol 2020.
[16]
Ruggiero G, Arcangeli F, Lotti T, et al. Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”. J Am Acad Dermatol 2020; 83(3): e237-9.[http://dx.doi.org/10.1016/j.jaad.2020.05.122] [PMID: 32497698]
[17]
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844-7.[http://dx.doi.org/10.1111/jth.14768] [PMID: 32073213]
[18]
Whitman PA, Crane JS. Pernio Chilblains 2020.
[19]
Bruni A, Garofalo E, Zuccalà V, et al. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis. World J Emerg Surg 2020; 15(1): 43.[http://dx.doi.org/10.1186/s13017-020-00320-5] [PMID: 32615987]
[20]
Schaller T, Hirschbühl K, Burkhardt K, et al. Postmortem Examination of Patients With COVID-19. JAMA 2020; 323(24): 2518-20.[http://dx.doi.org/10.1001/jama.2020.8907] [PMID: 32437497]
[21]
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383(2): 120-8.[http://dx.doi.org/10.1056/NEJMoa2015432] [PMID: 32437596]
[22]
Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020; 18(5): 1023-6.[http://dx.doi.org/10.1111/jth.14810] [PMID: 32338827]
[23]
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[24]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395(10229): 1054-62.[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]
[25]
Landa N, Mendieta-Eckert M, Fonda-Pascual P, Aguirre T. Chilblain-like lesions on feet and hands during the COVID-19 Pandemic. Int J Dermatol 2020; 59(6): 739-43.[http://dx.doi.org/10.1111/ijd.14937] [PMID: 32329897]
[26]
Beeching NJ, Fletcher TE, Beadsworth MBJ. Covid-19: Testing times. BMJ 2020; 369: m1403.[http://dx.doi.org/10.1136/bmj.m1403] [PMID: 32269032]
[27]
Winichakoon P, Chaiwarith R, Liwsrisakun C, et al. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19. J Clin Microbiol 2020; 58(5): e00297-20.[http://dx.doi.org/10.1128/JCM.00297-20] [PMID: 32102856]
[28]
Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 2003; 361(9371): 1767-72.[http://dx.doi.org/10.1016/S0140-6736(03)13412-5] [PMID: 12781535]
[29]
Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis 2014; 210(10): 1590-4.[http://dx.doi.org/10.1093/infdis/jiu292] [PMID: 24837403]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 2
Year: 2021
Published on: 16 October, 2020
Page: [216 - 219]
Pages: 4
DOI: 10.2174/1574887115666201016153031
Price: $65

Article Metrics

PDF: 50
HTML: 1